17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.
about
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cellsThe Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosisIncreasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotidesEstrogenic control of mitochondrial function and biogenesisPhenotypic anchoring of gene expression changes during estrogen-induced uterine growth.Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerThe p53-estrogen receptor loop in cancerProfiling of luteal transcriptome during prostaglandin F2-alpha treatment in buffalo cows: analysis of signaling pathways associated with luteolysis17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol productionPhosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistanceAnti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cellsDexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cellsEstrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independenceMultiwall Carbon Nanotube-Induced Apoptosis and Antioxidant Gene Expression in the Gills, Liver, and Intestine of Oryzias latipesProliferation and apoptosis in mammary epithelium during the rat oestrous cycleEstrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cellsSoy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV434 cell line.Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signalingIdentification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling.DNA plasticity is a key determinant of the energetics of binding of Jun-Fos heterodimeric transcription factor to genetic variants of TGACGTCA motif.Effect of Modulation of hnRNP L Levels on the Decay of bcl-2 mRNA in MCF-7 Cells.Estrogen induces Vav1 expression in human breast cancer cells.Age-associated prognostic and predictive biomarkers in patients with breast cancer.Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cellsNiche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.Induction of cytochrome P450 1A1 in MCF-7 human breast cancer cells by 4-chlorobiphenyl (PCB3) and the effects of its hydroxylated metabolites on cellular apoptosisInositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth.An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells.Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes.Estrogen receptor interaction with estrogen response elementsEstrogen-induced apoptosis of breast epithelial cells is blocked by NO/cGMP and mediated by extranuclear estrogen receptors.Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG studyEstrogen induces global reorganization of chromatin structure in human breast cancer cellsFunctional role of estrogen in pituitary tumor pathogenesis.Estrogen alters thresholds for B cell apoptosis and activation
P2860
Q24304287-30447FF2-E2E6-4246-BC8E-A82AC14C07F1Q24622720-25EE86EF-258A-415D-908E-70A2F481E4EFQ24645148-0D66BFBC-A20E-43D8-8879-0CAE5D733D30Q24651145-EF17B796-63EA-4E28-BFE0-ABDEDAFD77D2Q24816479-F7A2997B-1E7E-4A8E-B76A-7C7A4C653F74Q26738987-7339715F-B700-4F89-B8C8-FEB8C75CA28BQ27027865-09338B1C-E651-4084-BA48-88FB23665212Q27316498-AFA7DCD3-3829-484F-B5CD-4E3C11ACDF67Q27659972-611AF847-2934-4587-90D5-C7225EA476AFQ28141690-D70A85DF-84A8-4959-978D-24DE4829FA20Q28359567-C571442A-5504-4946-A0C9-B869B292432CQ28366553-F524BEDD-57D1-45EF-8947-CCF26B07A33DQ28396413-AAE4B665-F8B2-4A08-AF9B-16C8FBF05708Q28396591-6D153655-6E59-41D6-AA2A-C0FBC5486A92Q28579601-1F4DA58C-7F1E-48EC-9DC8-C49D0E8EA721Q28740916-F08BDB8A-D4B1-41C7-825E-B963D3F535A9Q30370581-2A836AE2-0B5C-4A43-94B9-C03C54CAAB75Q30419271-9D4371A9-A853-4744-A32E-4981B0318CBFQ33361574-14E2EE52-AF10-4DA7-BC08-4BFFB13FD157Q33375216-19AE8F7B-DAAA-4FF1-8710-4E310C7862A0Q33594194-530D5491-E259-4CA5-8BFE-A3C58A5A0617Q33717157-1F8CA26C-0529-45EE-99FD-65EBDB797548Q33721430-F52BDDCF-B95E-4C68-ABBE-72A1676BEDB0Q33750880-1386EB46-77BF-47E8-824B-3926842707CDQ33763624-55843808-B994-4431-A1B0-56509A178C52Q33767497-27AE6691-75BF-457B-AE3D-8913229ABA24Q33925127-587181DE-C4FB-4445-830C-EF5367ADCC95Q33996327-5A4BCFE0-C1A5-4CAD-BF51-7EAE024DB8D0Q34004585-34E25AB7-EF67-434B-9D4B-A5A9BF935039Q34006810-67188DF2-7BE0-4D0C-9E98-470F8BF936FEQ34133268-704BA0EE-0295-492E-99E4-0E1CAB8F8431Q34183355-E00DAB0F-5E9E-44D4-BC02-0A23BEDE3894Q34307898-4F702CC1-64BA-4A4A-AB6C-2D584DCF920FQ34392623-4F4A9F22-11C6-4782-B3FD-4B0A52F9B95AQ34440985-6C4C9EA3-F818-4695-B70D-88D3EC4A0A2BQ34491903-506ECA46-9DE9-4E87-9970-508514F6901CQ34559124-BA398130-F59D-4189-BEDD-E92667A63EBEQ34627952-BFD74A93-355E-416A-9ED1-BCB97FB8413AQ34787089-2AFA0902-7BB8-4E18-8A55-51769FF035BCQ34792410-224830D0-B771-4821-BA4D-FCC5891ED292
P2860
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@ast
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@en
type
label
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@ast
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@en
prefLabel
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@ast
17beta-estradiol inhibits apop ...... resent in the coding sequence.
@en
P2860
P50
P1476
17beta-estradiol inhibits apop ...... present in the coding sequence
@en
P2093
P2860
P304
P356
10.1128/MCB.20.8.2890-2901.2000
P407
P577
2000-04-01T00:00:00Z